Clearer INNs Required On Pack Labels As New Australian Rules Kick In
Executive Summary
Pharmaceutical companies marketing medicines in Australia have four years in which to comply with new pack label rules, which include clearer printing of the INN, minimum text sizes, and a machine-readable code, and are intended to improve consumer understanding and reduce medication errors.
You may also be interested in...
Australia Allows More Time For Labeling Compliance Due To COVID-19
The Australian medicines regulators is allowing sponsors of non-prescription drugs to request an additional six months to transition to new labeling requirements that will become mandatory as of September.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.